Deep learning methods for drug response prediction in cancer: predominant and emerging trends

• URL: http://arxiv.org/abs/2211.10442v1
• Date: Fri, 18 Nov 2022 03:26:31 GMT
• Title: Deep learning methods for drug response prediction in cancer: predominant and emerging trends
• Authors: Alexander Partin (1), Thomas S. Brettin (1), Yitan Zhu (1), Oleksandr Narykov (1), Austin Clyde (1 and 2), Jamie Overbeek (1), Rick L. Stevens (1 and 2) ((1) Division of Data Science and Learning, Argonne National Laboratory, Argonne, IL, USA, (2) Department of Computer Science, The University of Chicago, Chicago, IL, USA)
• Abstract summary: Exploiting computational predictive models to study and treat cancer holds great promise in improving drug development and personalized design of treatment plans. A wave of recent papers demonstrates promising results in predicting cancer response to drug treatments while utilizing deep learning methods. This review allows to better understand the current state of the field and identify major challenges and promising solution paths.
• Score: 50.281853616905416
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Cancer claims millions of lives yearly worldwide. While many therapies have been made available in recent years, by in large cancer remains unsolved. Exploiting computational predictive models to study and treat cancer holds great promise in improving drug development and personalized design of treatment plans, ultimately suppressing tumors, alleviating suffering, and prolonging lives of patients. A wave of recent papers demonstrates promising results in predicting cancer response to drug treatments while utilizing deep learning methods. These papers investigate diverse data representations, neural network architectures, learning methodologies, and evaluations schemes. However, deciphering promising predominant and emerging trends is difficult due to the variety of explored methods and lack of standardized framework for comparing drug response prediction models. To obtain a comprehensive landscape of deep learning methods, we conducted an extensive search and analysis of deep learning models that predict the response to single drug treatments. A total of 60 deep learning-based models have been curated and summary plots were generated. Based on the analysis, observable patterns and prevalence of methods have been revealed. This review allows to better understand the current state of the field and identify major challenges and promising solution paths.

Related papers

• An Explainable AI Model for Predicting the Recurrence of Differentiated Thyroid Cancer [0.0]
  This study employs machine learning, particularly deep learning models, to predict the recurrence of thyroid cancer. By analysing a dataset containing clinicopathological features of patients, the model achieved remarkable accuracy rates of 98% during training and 96% during testing.
  arXiv  Detail & Related papers  (2024-10-13T23:12:33Z)
• WISER: Weak supervISion and supErvised Representation learning to improve drug response prediction in cancer [7.9505208530650995]
  Cancer is a leading cause of death globally due to genomic changes and manifests heterogeneously across patients. variations in the distribution of genomic data and drug responses between cell lines and humans arise due to biological and environmental differences. Recent cancer drug response prediction methods have largely followed the paradigm of unsupervised domain-invariant representation learning. This paper addresses these challenges through a novel representation learning method in the first phase and weak supervision in the second.
  arXiv  Detail & Related papers  (2024-05-07T07:21:20Z)
• Recent Advances in Predictive Modeling with Electronic Health Records [71.19967863320647]
  utilizing EHR data for predictive modeling presents several challenges due to its unique characteristics. Deep learning has demonstrated its superiority in various applications, including healthcare.
  arXiv  Detail & Related papers  (2024-02-02T00:31:01Z)
• Safe AI for health and beyond -- Monitoring to transform a health service [51.8524501805308]
  We will assess the infrastructure required to monitor the outputs of a machine learning algorithm. We will present two scenarios with examples of monitoring and updates of models.
  arXiv  Detail & Related papers  (2023-03-02T17:27:45Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• A Deep Bayesian Bandits Approach for Anticancer Therapy: Exploration via Functional Prior [13.368491963797151]
  personalized cancer treatment with machine learning holds great promise to improve cancer patients' chance of survival. Despite recent advances in machine learning and precision oncology, this approach remains challenging. We formulate drug screening study as a "contextual bandit" problem, in which an algorithm selects anticancer therapeutics based on contextual information about cancer cell lines. We propose using a novel deep Bayesian bandits framework that uses functional prior to approximate posterior for drug response prediction based on multi-modal information consisting of genomic features and drug structure.
  arXiv  Detail & Related papers  (2022-05-05T21:56:14Z)
• Deep learning for drug repurposing: methods, databases, and applications [54.08583498324774]
  Repurposing existing drugs for new therapies is an attractive solution that accelerates drug development at reduced experimental costs. In this review, we introduce guidelines on how to utilize deep learning methodologies and tools for drug repurposing.
  arXiv  Detail & Related papers  (2022-02-08T09:42:08Z)
• Select-ProtoNet: Learning to Select for Few-Shot Disease Subtype Prediction [55.94378672172967]
  We focus on few-shot disease subtype prediction problem, identifying subgroups of similar patients. We introduce meta learning techniques to develop a new model, which can extract the common experience or knowledge from interrelated clinical tasks. Our new model is built upon a carefully designed meta-learner, called Prototypical Network, that is a simple yet effective meta learning machine for few-shot image classification.
  arXiv  Detail & Related papers  (2020-09-02T02:50:30Z)
• Divide-and-Rule: Self-Supervised Learning for Survival Analysis in Colorectal Cancer [9.431791041887957]
  We propose a self-supervised learning method that learns a representation of tissue regions as well as a metric of the clustering to obtain their underlying patterns. We show that the proposed approach can benefit from linear predictors to avoid overfitting in patient outcomes predictions.
  arXiv  Detail & Related papers  (2020-07-07T09:15:36Z)
• Deep neural network models for computational histopathology: A survey [1.2891210250935146]
  deep learning has become the mainstream methodological choice for analyzing and interpreting cancer histology images. In this paper, we present a comprehensive review of state-of-the-art deep learning approaches that have been used. We highlight critical challenges and limitations with current deep learning approaches, along with possible avenues for future research.
  arXiv  Detail & Related papers  (2019-12-28T01:04:25Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.